Peter Jan Sture Ström
Directeur/Bestuurslid bij WNTRESEARCH AB
Oorsprong van het eerstegraads netwerk van Peter Jan Sture Ström
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Other | 21 | |
Stockholm Corporate Finance AB
Stockholm Corporate Finance AB Investment ManagersFinance Stockholm Corporate Finance AB operates as an independent and privately-owned financial company, which offers financial advisory by taking transaction initiatives, acting in an advisory capacity, and assisting with transaction process implementation. The firm works closely with owners, board members, and management in listed and privately held companies. The company was founded by Harry Nudel and Gunnar Wedfelt in 2004 and is headquartered in Stockholm, Sweden.
9
| Subsidiary | Investment Managers | 9 |
Wntresearch Incentive AB
3
| Private Company | 3 | |
DentoSystem Scandinavia AB
DentoSystem Scandinavia AB Medical/Nursing ServicesHealth Services DentoSystem Scandinavia AB engages in the provision of dental care services. It develops artificial teeth, dentures, and dental plates. The company was founded by Sven Fredrik Lindskog and Leif Blomlöf in August 9, 1995 and is headquartered in Stockholm, Sweden.
1
| Private Company | Medical/Nursing Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Peter Jan Sture Ström via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
University of Lund | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Masters Business Admin Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
University of Gothenburg | College/University | Corporate Officer/Principal Masters Business Admin Graduate Degree Doctorate Degree | |
University of Stockholm | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
University of Uppsala | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
PROBI AB | Biotechnology | Director/Board Member Director/Board Member | |
Stockholm School of Economics | College/University | Corporate Officer/Principal Masters Business Admin | |
IDOGEN AB (PUBL) | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Targinta AB
Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Biotechnology | Chief Executive Officer | |
OxyPharma AB | Chief Executive Officer | ||
VIVESTO AB | Pharmaceuticals: Generic | Chief Executive Officer | |
ORION OYJ | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Synartro AB | Chief Tech/Sci/R&D Officer | ||
Mindforce Game Lab AB
Mindforce Game Lab AB Packaged SoftwareTechnology Services Mindforce Game Lab AB creates games for people with medical conditions, called Playtients™, to help them develop healthy habits. The games are designed to act as companions on the journey to better health and are created by bringing together leading life scientists and top game designers. The CEO of the Swedish company is Anders Rabbe. | Packaged Software | Chief Executive Officer | |
Aptahem AB
Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Chief Operating Officer | |
NIMUTAN AB (PUBL) | Household/Personal Care | Director/Board Member | |
ANNEXIN PHARMACEUTICALS AB | Pharmaceuticals: Major | Director/Board Member | |
LIPUM AB | Biotechnology | Chairman | |
REDWOOD PHARMA AB | Pharmaceuticals: Major | Chairman | |
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Director/Board Member | |
Epicyt Pharma AB
Epicyt Pharma AB Pharmaceuticals: MajorHealth Technology Epicyt Pharma AB is a Swedish pharmaceutical research company that was founded in 2016 by Ville Wallenius and Lars Fändriks. The company is based in Mölndal, Sweden. Epicyt Pharma develops the drug candidate BAFA. | Pharmaceuticals: Major | Director/Board Member | |
ALLIGATOR BIOSCIENCE AB | Biotechnology | Chief Executive Officer | |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
XINTELA AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
InDex Diagnostics AB
InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member | |
INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Chief Operating Officer | |
EVAXION BIOTECH A/S | Biotechnology | Chief Executive Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Operating Officer | |
Innovativa Mindre Life Science
Innovativa Mindre Life Science Miscellaneous Commercial ServicesCommercial Services Innovativa Mindre Life Science is an association of small and medium-sized Swedish companies that conduct research in the field of pharmaceuticals and medical technology. | Miscellaneous Commercial Services | Director/Board Member | |
ALZINOVA AB | Pharmaceuticals: Major | Director/Board Member | |
Swedish Export Credit Corp.
Swedish Export Credit Corp. Finance/Rental/LeasingFinance Swedish Export Credit Corp. engages in the provision of financial solutions on commercial terms by granting export credits and direct lending to exporters. It also administers the state-supported export credit system, CIRR. It offers export credits, lending, structured financing, project financing, leasing, capital market products, and financial advisory services. It also offers its solutions to corporations, the public sector, financial institutions as well as domestic and international capital investors. The company was founded in 1962 and is headquartered in Stockholm, Sweden. | Finance/Rental/Leasing | Director/Board Member | |
Ub-Consulting AB | Chief Executive Officer | ||
A Bioscience Incentive AB | Chairman | ||
New York University School of Law | College/University | Graduate Degree | |
Teva GmbH
Teva GmbH Medical DistributorsDistribution Services Part of Teva Pharmaceutical Industries Ltd., Teva GmbH is a German company that aims to provide high-quality medicines to improve the quality of life of patients. The company is based in Ulm, Germany. The CEOs are Thomas Andreas Schlenker, Andreas Burkhardt, Christoph Stoller. The company was founded in 2011. | Medical Distributors | Corporate Officer/Principal | |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Atlas Therapeutics AB
Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member | |
The University of North Carolina at Charlotte | College/University | Corporate Officer/Principal | |
Fermion Ltd. | Director/Board Member | ||
Orion Diagnostica AB | Director/Board Member | ||
Telge Bostäder AB
Telge Bostäder AB Real Estate DevelopmentFinance Telge Bostäder AB is the Swedish largest housing company in Södertälje, SE, founded in 1948 and ultimately controlled by the City of Södertälje (Sweden). The company owns and manages approximately 10,000 apartments and follows a self-cost principle for water and sewage. Telge Bostäder offers various services to its tenants, including waste management, where food waste is converted into biogas and bio-fertilizer. The company also provides support to customers with high electricity prices. Additionally, Telge Bostäder promotes upcycling to save the earth's resources. The CEO is Pontus Werlinder. | Real Estate Development | Director of Finance/CFO | |
Helsingborgshem AB
Helsingborgshem AB Real Estate DevelopmentFinance Helsingborgshem AB operates as a regional housing company that owns and operates apartments and commercial properties. It offers ordinary apartments of various sizes and designs, townhouses, student rooms, senior housing, and collective housing. The company was founded in 1946 and is headquartered in Helsingborg, Sweden. | Real Estate Development | Director of Finance/CFO | |
International Women's Forum Sweden | Chairman | ||
Human Search | Chairman |
Statistieken
Internationaal
Zweden | 41 |
Verenigde Staten | 6 |
Finland | 2 |
Denemarken | 2 |
Duitsland | 2 |
Sectoraal
Health Technology | 27 |
Consumer Services | 9 |
Finance | 4 |
Commercial Services | 3 |
Technology Services | 2 |
Operationeel
Director/Board Member | 99 |
Corporate Officer/Principal | 47 |
Chief Executive Officer | 23 |
Chairman | 21 |
Chief Operating Officer | 14 |
Sterkste connecties
Insiders | |
---|---|
Kjell Sture Stenberg | 29 |
Dennis Bang Henriksen | 19 |
Marie Reinius | 18 |
Ulf Björklund | 14 |
Ulla Hald Buhl | 12 |
Jan Nilsson | 12 |
Per-Ola Forsberg | 11 |
Christer Nordstedt | 10 |
Per Norlén | 9 |
Anders Rabbe | 9 |
Ulf Fredrik Werner Risberg | 9 |
Pernilla Sandwall | 8 |
Daniel Hofmann | 7 |
Tommy Evert Andersson | 6 |
Martin Olovsson | 6 |
- Beurs
- Insiders
- Peter Jan Sture Ström
- Bedrijfsconnecties